XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 1,591 $ (183)
Adjustment to reconcile net income (loss) from continuing operations to net cash provided by operating activities    
Amortization of loan discount, loan commitment and deferred financing fees 27 82
Amortization and depreciation expense 176 103
Earnings from unconsolidated joint venture, net of distributions 114 9
Stock compensation 595 345
Change in fair value of equity method investment 134 606
Distributions from equity method investments carried at fair value 1,322 100
Changes in operating assets and liabilities:    
Trade receivables - related party 628 463
Trade receivables 251 19
Accrued personnel costs (1,567) (42)
Prepaid and other assets (80) 91
Accrued interest 0 (1)
Accrued liabilities 601 488
Accounts payable (1,130) (2,596)
Net cash provided by operating activities of discontinued operations 0 7,429
Net cash provided by operating activities 2,662 6,913
Cash flows from investing activities:    
Purchase of fixed assets (114) (126)
Principal received on note receivable 0 27
Net cash used in investing activities (114) (99)
Cash flows from financing activities:    
Proceeds from notes payable 5,554 0
Payments on notes payable (7,054) (172)
Taxes paid related to net share settlement of equity awards (68) 6
Net cash used in financing activities (1,568) (166)
Net increase in cash and cash equivalents 980 6,648
Cash and cash equivalents, beginning of period 3,511 854
Cash and cash equivalents, end of period 4,491 7,502
Supplemental cash flow information:    
Interest paid 338 440
Supplemental disclosure for non-cash investing and financing activities:    
Accrued liability settled through issuance of stock 54 106
Gain on early extinguishment of debt $ 50 $ 0